CVS Health Corp. CVS 4.78% first-quarter sales rose more than 11% as the pharmacy chain continued to benefit from administering Covid-19 vaccines and selling at-home tests.
The Woonsocket, R.I.-based company said Wednesday that it expects demand for Covid testing and vaccines to lift sales throughout 2023.
“Many like to model Covid going to zero for retail, and that’s a convenient modeling assumption, but I think a very highly unlikely outcome for 2023 as we move from pandemic to endemic,” CVS Chief Financial Officer Shawn Guertin said on a call with analysts.
Source: WSJ